Clinical trial
Safety of Rabeprazole in Patients Under Multiple Treatments
NCT00511745 is registered in ClinicalTrials.gov with Janssen-Cilag, S.A. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety of Rabeprazole in Patients Under Multiple Treatments
- Lead sponsor
- Janssen-Cilag, S.A.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- Not reported
- Completion date
- November 30, 2002
- Enrollment
- 2,157 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
gastric ulcer, gastroesophageal reflux